Download pdf
New
EBMT partners in a new consortium to decentralise CAR-T cell therapy and improve hospital workflow
The newly launched EASYGEN (Easy workflow integration for gene therapy) consortium will develop a fully automated, hospital-based platform capable of manufacturing personalised cell therapies within a few days. Fresenius SE & Co.